Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 VaccineStephen J. Thomas, Kathrin U. Jansen, John L. Perez et al.|medRxiv|2021Cited by 144
Molecular characterization of Clostridioides difficile isolated from older adults during prospective population-based active surveillance at nine hospitals in Tokyo, Japan, 2018–2020Zhenghui Li, Kazuhiro Tateda, Ashlesh K. Murthy et al.|Anaerobe|2025Cited by 1
Plain Language Summary of Pfizer-BioNTech BNT162b2 COVID-19 Vaccine Safety in Participants at Least 16 Years Old and Protection Against COVID-19 in Participants at Least 12 Years OldStephen J. Thomas, Kathrin U. Jansen, Edson Duarte Moreira et al.|Future Virology|2022Cited by 0